SimonMed is expanding its AI-enabled imaging platform across its national outpatient network, embedding U.S. Food and Drug Administration (FDA)-cleared technologies into routine diagnostic exams.
The expansion introduces three new offerings -- Calcium Score+, CT Bone Density, and MR Lumbar Spine+ -- which apply AI to standard imaging exams to provide additional clinical insights without requiring extra scan time or radiation exposure, according to the company.
Calcium Score+ enhances coronary calcium scoring with AI-enabled analysis to help quantify calcified plaque from existing CT images. CT Bone Density uses AI to assess bone mineral density opportunistically from CT scans that include the spine, enabling evaluation of bone health without a dedicated DEXA exam. MR Lumbar Spine+ applies AI to standard lumbar MRI exams to generate quantitative measurements, severity grading, and annotated visualizations, the firm said. Both Calcium Score+ and CT Bone Density can be added to non-contrast CT chest exams, including lung cancer screening.
Patients who opt into the services receive results through SimonMed's Digital Health Platform, a mobile-first tool that includes summaries, visual explanations, and access to a patient navigator for follow-up care coordination, the company said.
